Kin-Ming Lo

Person

Lexington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Targeted TGFβ inhibition
- Patent number 11,370,819
- Issue date Jun 28, 2022
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
SIRP-α immunoglobulin fusion proteins
- Patent number 11,021,694
- Issue date Jun 1, 2021
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeted TGFβ inhibitors
- Patent number 9,676,863
- Issue date Jun 13, 2017
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cancer using interleukin-12p40 variants having...
- Patent number 9,029,330
- Issue date May 12, 2015
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody fusion proteins with a modified FcRn binding site
- Patent number 8,907,066
- Issue date Dec 9, 2014
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Expression and export of angiogenesis inhibitors as immunofusins
- Patent number 8,703,908
- Issue date Apr 22, 2014
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered anti-alpha V-integrin hybrid antibodies
- Patent number 8,562,986
- Issue date Oct 22, 2013
- Merck Patent GmbH
- Simon Goodman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilization of Fc-interferon-beta fusion proteins
- Patent number 8,557,232
- Issue date Oct 15, 2013
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunocytokine sequences and uses thereof
- Patent number 8,470,991
- Issue date Jun 25, 2013
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-12 targeted to oncofoetal fibronectin
- Patent number 8,420,087
- Issue date Apr 16, 2013
- Antisoma Research Limited
- Stephen Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Expression and export of angiogenesis inhibitors as immunofusins
- Patent number 8,206,718
- Issue date Jun 26, 2012
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding interleukin-12P40 variants with improved sta...
- Patent number 8,188,248
- Issue date May 29, 2012
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteins comprising an IgG2 domain
- Patent number 8,066,994
- Issue date Nov 29, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using Fc-cytokine fusion proteins
- Patent number 8,043,608
- Issue date Oct 25, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc fusion proteins for enhancing the immunogenicity of protein and...
- Patent number 7,955,590
- Issue date Jun 7, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding IL-2 fusion proteins with modulated selectivity
- Patent number 7,888,071
- Issue date Feb 15, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Patent number 7,879,319
- Issue date Feb 1, 2011
- Merk Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-12p40 variants with improved stability
- Patent number 7,872,107
- Issue date Jan 18, 2011
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant tumor specific antibody and use thereof
- Patent number 7,803,618
- Issue date Sep 28, 2010
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhancing the circulating half-life of antibody-based fusion proteins
- Patent number 7,790,415
- Issue date Sep 7, 2010
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunocytokine sequences and uses thereof
- Patent number 7,767,405
- Issue date Aug 3, 2010
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc-interferon-beta fusion proteins
- Patent number 7,670,595
- Issue date Mar 2, 2010
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of targeting multiple cytokines
- Patent number 7,582,288
- Issue date Sep 1, 2009
- Merck Patent GmbH
- Stephen D. Gillies
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Patent number 7,576,193
- Issue date Aug 18, 2009
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhancing the circulating half-life of antibody-based fusion proteins
- Patent number 7,507,406
- Issue date Mar 24, 2009
- EMD Serono Research Center, Inc.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer treatments including administering IL-2 fusion proteins with...
- Patent number 7,462,350
- Issue date Dec 9, 2008
- EMD Serono Research Center, Inc.
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant tumor specific antibody and use thereof
- Patent number 7,459,538
- Issue date Dec 2, 2008
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Patent number 7,226,998
- Issue date Jun 5, 2007
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-2 fusion proteins with modulated selectivity
- Patent number 7,186,804
- Issue date Mar 6, 2007
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunocytokine sequences and uses thereof
- Patent number 7,169,904
- Issue date Jan 30, 2007
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TARGETED TGFß INHIBITION
- Publication number 20230056881
- Publication date Feb 23, 2023
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy for Cancer
- Publication number 20220017621
- Publication date Jan 20, 2022
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED TGFß INHIBITION
- Publication number 20200055949
- Publication date Feb 20, 2020
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR CANCER
- Publication number 20180118832
- Publication date May 3, 2018
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED TGFß INHIBITION
- Publication number 20180002436
- Publication date Jan 4, 2018
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SIRP-ALPHA IMMUNOGLOBULIN FUSION PROTEINS
- Publication number 20160177276
- Publication date Jun 23, 2016
- Merck Patent GmbH
- Kin-Ming Lo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TETRAVALENT BISPECIFIC ANTIBODIES
- Publication number 20160009824
- Publication date Jan 14, 2016
- Merck Patent GmbH
- Kin-Ming LO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Fusion Proteins with a Modified FcRn Binding Site
- Publication number 20150274797
- Publication date Oct 1, 2015
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED TGFß INHIBITION
- Publication number 20150225483
- Publication date Aug 13, 2015
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FC-Interferon-Beta Fusion Proteins
- Publication number 20140005361
- Publication date Jan 2, 2014
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION AND EXPORT OF ANGIOGENESIS INHIBITORS AS IMMUNOFUSINS
- Publication number 20130165634
- Publication date Jun 27, 2013
- Merck Patent GmbH
- Kin-Ming Lo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Interleukin-12 P40 Variants with Improved Stability
- Publication number 20130034518
- Publication date Feb 7, 2013
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES
- Publication number 20130017168
- Publication date Jan 17, 2013
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-12P40 VARIANTS WITH IMPROVED STABILITY
- Publication number 20110097792
- Publication date Apr 28, 2011
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-6 ANTAGONISTS
- Publication number 20110038877
- Publication date Feb 17, 2011
- Merck Patent GmbH
- Jeffrey Way
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody Fusion Proteins with a Modified FcRn Binding Site
- Publication number 20100272720
- Publication date Oct 28, 2010
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED ANTI-ALPHA V-INTEGRIN HYBRID ANTIBODIES
- Publication number 20100254977
- Publication date Oct 7, 2010
- Merck Patent GmbH
- Simon Goodman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunocytokine Sequences and Uses Thereof
- Publication number 20100210831
- Publication date Aug 19, 2010
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT TUMOR SPECIFIC ANTIBODY AND USE THEREOF
- Publication number 20100174056
- Publication date Jul 8, 2010
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of using Fc-Cytokine fusion proteins
- Publication number 20100068175
- Publication date Mar 18, 2010
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC FUSION PROTEINS USEFUL FOR TARGETED IMMUNE THERAPY AN...
- Publication number 20100015089
- Publication date Jan 21, 2010
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCING THE CIRCULATING HALF-LIFE OF ANTIBODY-BASED FUSION PROTEINS
- Publication number 20090264627
- Publication date Oct 22, 2009
- EMD Serono Research Center, Inc.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ASSEMBLY AND FOLDING OF FC-INTERFERON-BETA FUSION PROTEINS
- Publication number 20090191154
- Publication date Jul 30, 2009
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2 FUSION PROTEINS WITH MODULATED SELECTIVITY
- Publication number 20090098609
- Publication date Apr 16, 2009
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENHANCING THE CIRCULATING HALF-LIFE OF ANTIBODY-BASED FUSION PROTEINS
- Publication number 20090088561
- Publication date Apr 2, 2009
- Merck Patent GmbH
- Stephen Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Publication number 20080311655
- Publication date Dec 18, 2008
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for enhancing the efficacy of IL-2 mediated immune responses
- Publication number 20080025947
- Publication date Jan 31, 2008
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multiple cytokine protein complexes
- Publication number 20070258944
- Publication date Nov 8, 2007
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds For Targeting
- Publication number 20070202103
- Publication date Aug 30, 2007
- EMD Lexigen Research Center Corp.
- Stephen Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Interleukin-6 antagonists
- Publication number 20070178098
- Publication date Aug 2, 2007
- Merck Patent GmbH
- Jeffrey Way
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kin-Ming Lo

Person

Patents Grantslast 30 patents

Targeted TGFβ inhibition

SIRP-α immunoglobulin fusion proteins

Targeted TGFβ inhibitors

Methods of treating cancer using interleukin-12p40 variants having...

Antibody fusion proteins with a modified FcRn binding site

Expression and export of angiogenesis inhibitors as immunofusins

Engineered anti-alpha V-integrin hybrid antibodies

Stabilization of Fc-interferon-beta fusion proteins

Immunocytokine sequences and uses thereof

Interleukin-12 targeted to oncofoetal fibronectin

Expression and export of angiogenesis inhibitors as immunofusins

Nucleic acids encoding interleukin-12P40 variants with improved sta...

Proteins comprising an IgG2 domain

Methods of using Fc-cytokine fusion proteins

Fc fusion proteins for enhancing the immunogenicity of protein and...

DNA encoding IL-2 fusion proteins with modulated selectivity

Heterodimeric fusion proteins useful for targeted immune therapy an...

Interleukin-12p40 variants with improved stability

Recombinant tumor specific antibody and use thereof

Enhancing the circulating half-life of antibody-based fusion proteins

Immunocytokine sequences and uses thereof

Fc-interferon-beta fusion proteins

Methods of targeting multiple cytokines

Heterodimeric fusion proteins useful for targeted immune therapy an...

Enhancing the circulating half-life of antibody-based fusion proteins

Cancer treatments including administering IL-2 fusion proteins with...

Recombinant tumor specific antibody and use thereof

Heterodimeric fusion proteins useful for targeted immune therapy an...

IL-2 fusion proteins with modulated selectivity

Immunocytokine sequences and uses thereof

Patents Applicationslast 30 patents

TARGETED TGFß INHIBITION

Combination Therapy for Cancer

TARGETED TGFß INHIBITION

COMBINATION THERAPY FOR CANCER

TARGETED TGFß INHIBITION

SIRP-ALPHA IMMUNOGLOBULIN FUSION PROTEINS

TETRAVALENT BISPECIFIC ANTIBODIES

Antibody Fusion Proteins with a Modified FcRn Binding Site

TARGETED TGFß INHIBITION

FC-Interferon-Beta Fusion Proteins

EXPRESSION AND EXPORT OF ANGIOGENESIS INHIBITORS AS IMMUNOFUSINS

Interleukin-12 P40 Variants with Improved Stability

METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES

INTERLEUKIN-12P40 VARIANTS WITH IMPROVED STABILITY

INTERLEUKIN-6 ANTAGONISTS

Antibody Fusion Proteins with a Modified FcRn Binding Site

ENGINEERED ANTI-ALPHA V-INTEGRIN HYBRID ANTIBODIES

Immunocytokine Sequences and Uses Thereof

RECOMBINANT TUMOR SPECIFIC ANTIBODY AND USE THEREOF

Methods of using Fc-Cytokine fusion proteins

HETERODIMERIC FUSION PROTEINS USEFUL FOR TARGETED IMMUNE THERAPY AN...

ENHANCING THE CIRCULATING HALF-LIFE OF ANTIBODY-BASED FUSION PROTEINS

ASSEMBLY AND FOLDING OF FC-INTERFERON-BETA FUSION PROTEINS

IL-2 FUSION PROTEINS WITH MODULATED SELECTIVITY

ENHANCING THE CIRCULATING HALF-LIFE OF ANTIBODY-BASED FUSION PROTEINS

Heterodimeric fusion proteins useful for targeted immune therapy an...

Methods for enhancing the efficacy of IL-2 mediated immune responses

Multiple cytokine protein complexes

Compounds For Targeting

Interleukin-6 antagonists